Patents by Inventor John D'Arco
John D'Arco has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20230277762Abstract: Disclosed herein is a combination of an automated insulin delivery system and a continuous glucose monitor integrated into a single, wearable package. The system may use any combination of delivery methods and detection methods, wherein the delivery methods include a cannula, a microneedle array, and a transdermal patch, and wherein the detection methods include electrochemical methods, opto-fluorescent methods, and spectrographic methods.Type: ApplicationFiled: March 1, 2023Publication date: September 7, 2023Inventors: Eric DUHAMEL, John D′ARCO, David NAZZARO, James CAUSEY
-
Patent number: 11744944Abstract: Systems and methods for automatically delivering medication to a user. A sensor coupled to a user can collect information regarding the user. A controller can use the collected information to determine an amount of medication to provide the user. The controller can instruct a drug delivery device to dispense the medication to the user. The drug delivery device can be a wearable insulin pump that is directly coupled to the user. The controller can be part of or implemented in a cellphone. A user can be required to provide a confirmation input to allow a determined amount of insulin to be provided to the user based on detected glucose levels of the user. The sensor, controller, and drug delivery device can communicate wirelessly.Type: GrantFiled: June 11, 2020Date of Patent: September 5, 2023Assignee: INSULET CORPORATIONInventors: Jason O'Connor, Daniel Allis, David Nazzaro, John R. Bussiere, John D'Arco
-
Publication number: 20230173173Abstract: A drug delivery device may include an Inertial Measurement Unit (IMU) is provided. The IMU may include an accelerometer, a magnetometer, or a gyroscope. Motion parameters may be detected when the drug delivery device is shipped, being prepared for activation for use, or during use. The IMU may provide data indicative of a rapid deceleration, such as when a package containing the drug delivery device is dropped, or some other physical event experienced by the drug delivery device. The drug delivery device may also include internal or external pressure sensors or a blood glucose sensor that may coordinate with the IMU to provide additional feedback regarding the status of the device or user. A controller of the drug delivery device may generate a response depending on the particular parameters being monitored or may change device operational parameters as a result of detected system events.Type: ApplicationFiled: January 27, 2023Publication date: June 8, 2023Inventors: Jason O'CONNOR, Joon Bok LEE, Ian MCLAUGHLIN, John D'ARCO
-
Publication number: 20230067014Abstract: The exemplary embodiments may account for a change in potency of a medicament and adjust the dosage of medicament delivered to a user via a medicament delivery device to compensate for the change in potency. The medicament delivery device may determine the amount of change in the potency in the medicament and may make the adjustment in dosage of the medicament delivered to the user automatically without user input. The net result in that the dosage of medicament delivered to the user is better matched to the user's true need for the medicament.Type: ApplicationFiled: August 24, 2022Publication date: March 2, 2023Inventors: Joon Bok LEE, John D'ARCO, David NAZZARO, Yibin ZHENG, Jason O'CONNOR
-
Patent number: 11565039Abstract: A drug delivery device may include an Inertial Measurement Unit (IMU) is provided. The IMU may include an accelerometer, a magnetometer, or a gyroscope. Motion parameters may be detected when the drug delivery device is shipped, being prepared for activation for use, or during use. The IMU may provide data indicative of a rapid deceleration, such as when a package containing the drug delivery device is dropped, or some other physical event experienced by the drug delivery device. The drug delivery device may also include internal or external pressure sensors or a blood glucose sensor that may coordinate with the IMU to provide additional feedback regarding the status of the device or user. A controller of the drug delivery device may generate a response depending on the particular parameters being monitored or may change device operational parameters as a result of detected system events.Type: GrantFiled: October 11, 2019Date of Patent: January 31, 2023Assignee: INSULET CORPORATIONInventors: Jason O'Connor, Joon Bok Lee, Ian McLaughlin, John D'Arco
-
Publication number: 20220233765Abstract: In an exemplary embodiment, a drug delivery device is configured for Body Channel Communication (BCC). The drug delivery device may include a conductive element embedded in an adhesive patch that secures the drug delivery device to the user. This conductive element acts as a coupler to the body of the user. Another conductive element may also be provided at a face of the housing. This conductive element acts as the other end of the coupler formed with the conductive coil in the adhesive patch. The conductive coil in the adhesive patch conforms well to the user's skin surface and thus facilitates a good quality coupling with the user.Type: ApplicationFiled: January 20, 2022Publication date: July 28, 2022Inventors: David NAZZARO, John D'ARCO, Nicholas CONTE, Kepei SUN
-
Publication number: 20220203022Abstract: An on-body drug delivery device may have one or more antennas secured outside a housing of the on-body drug delivery device for facilitating wireless communications. The one or more antennas may be secured to an adhesive pad that adheres the on-body drug delivery device to a user. Alternatively, the one or more antennas may be secured to a portion of the housing for the on-body drug delivery device. In such instances, the one or more antennas may pass through one or more holes in the housing to facilitate an electrical connection with a component, like a wireless communications transceiver, inside the housing. Alternatively, wireless communications with the one or more antennas and the component may be used.Type: ApplicationFiled: December 16, 2021Publication date: June 30, 2022Inventors: David NAZZARO, John D'ARCO, Nicholas CONTE, Kepei SUN
-
Publication number: 20220192543Abstract: Exemplary embodiments may provide an adhesive pad that is designed to be used with an on-body medical device. The adhesive pad may partially or fully surround a perimeter of the on-body medical device. The adhesive pad may be the primary mechanism or may provide an additional mechanism for helping to secure the on-body medical device to the user. In addition, the adhesive pad may include a metallic coil, such as a metal loop, that is woven into the adhesive pad or otherwise inserted into or secured to the adhesive pad. The metallic coil may play multiple roles. First, the metallic coil may act as an antenna to facilitate wireless communications with the on-body medical device, such as NFC communications. In addition, the metallic coil may serve as a power source for electric components positioned on the adhesive pad.Type: ApplicationFiled: December 17, 2021Publication date: June 23, 2022Inventors: David NAZZARO, John D'ARCO, Nicholas CONTE, Kepei SUN
-
Publication number: 20220096746Abstract: A drug delivery system having a drug delivery device and an associated sensor is provided. The sensor can be associated with a sensing site on user. The drug delivery device can be positioned over the sensor in any rotational position and can be associated with an infusion site on the user. The close positioning of the sensor and the drug delivery device allows data from the sensor to be relayed to the drug delivery device and then on to a remote control device. Further, the drug delivery device can be replaced at the end of its duration of use, which is shorter than the duration of use of the sensor, without disturbing the sensor. Subsequent drug delivery devices can then be used with the sensor while allowing each corresponding infusion site to be changed, thereby providing more efficient operation of the drug delivery system.Type: ApplicationFiled: December 8, 2021Publication date: March 31, 2022Inventors: David NAZZARO, John D`ARCO, Jason O'CONNOR, Ian MCLAUGHLIN
-
Patent number: 11241532Abstract: A drug delivery system having a drug delivery device and an associated sensor is provided. The sensor can be associated with a sensing site on user. The drug delivery device can be positioned over the sensor in any rotational position and can be associated with an infusion site on the user. The close positioning of the sensor and the drug delivery device allows data from the sensor to be relayed to the drug delivery device and then on to a remote control device. Further, the drug delivery device can be replaced at the end of its duration of use, which is shorter than the duration of use of the sensor, without disturbing the sensor. Subsequent drug delivery devices can then be used with the sensor while allowing each corresponding infusion site to be changed, thereby providing more efficient operation of the drug delivery system.Type: GrantFiled: August 29, 2018Date of Patent: February 8, 2022Assignee: INSULET CORPORATIONInventors: David Nazzaro, John D'Arco, Jason O'Connor, Ian McLaughlin
-
Publication number: 20210379282Abstract: Systems and methods for automatically delivering medication to a user. An automated drug delivery system may include a sensor and a wearable automated drug delivery device. The wearable automated drug delivery device may be configured to couple to the skin of a user and may include a controller and a pump. The pump may be configured to output the medication. The controller may be within the wearable automated drug delivery device. The sensor may be coupled to the user and may be configured to collect information regarding the user. The controller of the wearable automated drug delivery device may use the collected information to locally determine an amount of medication to be output from the wearable automated drug delivery device and cause delivery of the amount of medication.Type: ApplicationFiled: August 16, 2021Publication date: December 9, 2021Inventors: Jason O'CONNOR, Daniel ALLIS, David NAZZARO, John R. Bussiere, John D'ARCO
-
Patent number: 11090434Abstract: Systems and methods for automatically delivering medication to a user. An automated drug delivery system may include a sensor and a wearable automated drug delivery device. The wearable automated drug delivery device may be configured to couple to the skin of a user and may include a controller and a pump. The pump may be configured to output the medication. The controller may be within the wearable automated drug delivery device. The sensor may be coupled to the user and may be configured to collect information regarding the user. The controller of the wearable automated drug delivery device may use the collected information to locally determine an amount of medication to be output from the wearable automated drug delivery device and cause delivery of the amount of medication.Type: GrantFiled: October 23, 2020Date of Patent: August 17, 2021Assignee: INSULET CORPORATIONInventors: Jason O'Connor, Daniel Allis, David Nazzaro, John R. Bussiere, John D'Arco
-
Publication number: 20210038813Abstract: Systems and methods for automatically delivering medication to a user. An automated drug delivery system may include a sensor and a wearable automated drug delivery device. The wearable automated drug delivery device may be configured to couple to the skin of a user and may include a controller and a pump. The pump may be configured to output the medication. The controller may be within the wearable automated drug delivery device. The sensor may be coupled to the user and may be configured to collect information regarding the user. The controller of the wearable automated drug delivery device may use the collected information to locally determine an amount of medication to be output from the wearable automated drug delivery device and cause delivery of the amount of medication.Type: ApplicationFiled: October 23, 2020Publication date: February 11, 2021Inventors: Jason O'CONNOR, Daniel ALLIS, David NAZZARO, John R. Bussiere, John D'ARCO
-
Publication number: 20200324048Abstract: Systems and methods for automatically delivering medication to a user. A sensor coupled to a user can collect information regarding the user. A controller can use the collected information to determine an amount of medication to provide the user. The controller can instruct a drug delivery device to dispense the medication to the user. The drug delivery device can be a wearable insulin pump that is directly coupled to the user. The controller can be part of or implemented in a cellphone. A user can be required to provide a confirmation input to allow a determined amount of insulin to be provided to the user based on detected glucose levels of the user. The sensor, controller, and drug delivery device can communicate wirelessly.Type: ApplicationFiled: June 11, 2020Publication date: October 15, 2020Inventors: Jason O'CONNOR, Daniel ALLIS, David NAZZARO, John R. Bussiere, John D'ARCO
-
Patent number: 10716896Abstract: Systems and methods for automatically delivering medication to a user. A sensor coupled to a user can collect information regarding the user. A controller can use the collected information to determine an amount of medication to provide the user. The controller can instruct a drug delivery device to dispense the medication to the user. The drug delivery device can be a wearable insulin pump that is directly coupled to the user. The controller can be part of or implemented in a cellphone. A user can be required to provide a confirmation input to allow a determined amount of insulin to be provided to the user based on detected glucose levels of the user. The sensor, controller, and drug delivery device can communicate wirelessly.Type: GrantFiled: November 22, 2016Date of Patent: July 21, 2020Assignee: INSULET CORPORATIONInventors: Jason O'Connor, Daniel Allis, David Nazzaro, John R. Bussiere, John D'Arco
-
Publication number: 20200113515Abstract: A drug delivery device may include an Inertial Measurement Unit (IMU) is provided. The IMU may include an accelerometer, a magnetometer, or a gyroscope. Motion parameters may be detected when the drug delivery device is shipped, being prepared for activation for use, or during use. The IMU may provide data indicative of a rapid deceleration, such as when a package containing the drug delivery device is dropped, or some other physical event experienced by the drug delivery device. The drug delivery device may also include internal or external pressure sensors or a blood glucose sensor that may coordinate with the IMU to provide additional feedback regarding the status of the device or user. A controller of the drug delivery device may generate a response depending on the particular parameters being monitored or may change device operational parameters as a result of detected system events.Type: ApplicationFiled: October 11, 2019Publication date: April 16, 2020Inventors: Jason O'CONNOR, Joon Bok LEE, Ian MCLAUGHLIN, John D'ARCO
-
Publication number: 20200069875Abstract: A drug delivery system having a drug delivery device and an associated sensor is provided. The sensor can be associated with a sensing site on user. The drug delivery device can be positioned over the sensor in any rotational position and can be associated with an infusion site on the user. The close positioning of the sensor and the drug delivery device allows data from the sensor to be relayed to the drug delivery device and then on to a remote control device. Further, the drug delivery device can be replaced at the end of its duration of use, which is shorter than the duration of use of the sensor, without disturbing the sensor. Subsequent drug delivery devices can then be used with the sensor while allowing each corresponding infusion site to be changed, thereby providing more efficient operation of the drug delivery system.Type: ApplicationFiled: August 29, 2018Publication date: March 5, 2020Inventors: David NAZZARO, John D`ARCO, Jason O'CONNOR, Ian MCLAUGHLIN
-
Publication number: 20170173261Abstract: Systems and methods for automatically delivering medication to a user. A sensor coupled to a user can collect information regarding the user. A controller can use the collected information to determine an amount of medication to provide the user. The controller can instruct a drug delivery device to dispense the medication to the user. The drug delivery device can be a wearable insulin pump that is directly coupled to the user. The controller can be part of or implemented in a cellphone. A user can be required to provide a confirmation input to allow a determined amount of insulin to be provided to the user based on detected glucose levels of the user. The sensor, controller, and drug delivery device can communicate wirelessly.Type: ApplicationFiled: November 22, 2016Publication date: June 22, 2017Inventors: Jason O'Connor, Daniel Allis, David Nazzaro, John R. Bussiere, John D'Arco
-
Publication number: 20080281378Abstract: A neurological diagnosis and/or treatment system comprising: (i) patient interface apparatus for interfacing with the patient so as to acquire desired data from the patient; (ii) a function-specific module for performing a desired diagnostic and/or therapeutic function on the patient via the patient interface apparatus; (iii) a controlling device for providing a user interface between a medical professional operating the system and the function-specific module, whereby to enable the medical professional to provide input to, and receive output from, the function-specific module; and (iv) a communications hub for connecting the controlling device with a documentation/analysis/storage center by means of a communications network; wherein the function-specific module is connected to the patient interface apparatus by a communications link, the function-specific module is connected to the controlling device by a communications link, and the controlling device is connected to the communications hub by a communicaType: ApplicationFiled: December 14, 2007Publication date: November 13, 2008Inventors: Michael Williams, Shai Gozani, John D'Arco
-
Patent number: D571372Type: GrantFiled: June 6, 2006Date of Patent: June 17, 2008Assignee: Neurometrix, Inc.Inventors: Paul E. Brefka, John D'Arco, Charles Fendrock, Michael Williams